A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
Sumitomo Pharma America, Inc.
Celgene
Shenzhen BinDeBio Ltd.
Celldex Therapeutics
Hoffmann-La Roche
Novartis
INSYS Therapeutics Inc